Cephracap DS 250 mg/5 ml (Powder for Suspension)

100 ml bottle: ৳ 120.00

Medicine Details

Category Details
Generic Cephradine
Company Euro pharma ltd
Also available as
Cephracap 500 mg capsule

Therapeutic Class

  • First generation Cephalosporins

Indications

  • Treatment of infections caused by sensitive Gram-positive and Gram-negative bacteria
  • Upper respiratory tract infections such as sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis, and otitis media
  • Lower respiratory tract infections including bronchitis, lobar pneumonia, and bronchopneumonia
  • Urinary tract infections such as cystitis, urethritis, and pyelonephritis
  • Skin and soft tissue infections like abscess, cellulitis, furunculosis, and impetigo

Pharmacology

  • Semisynthetic broad spectrum bactericidal antibiotic
  • Active against both gram-positive and gram-negative microorganisms
  • Inhibits cross-linking process in the cell wall of bacteria

Dosage & Administration

  • For oral administration in adults and children
  • For injectable administration in adults and children
  • Dosage adjustment necessary in renal impairment

Interaction

  • Concomitant use of nephrotoxic drugs may increase the risk of kidney damage
  • Diuretics and probenecid enhanced possibility of renal toxicity

Contraindications

  • Not to be used in patients with known or suspected hypersensitivity to cephalosporins

Side Effects

  • Gastro-intestinal disturbances
  • Hypersensitivity phenomena
  • Rare side effects like glossitis, heartburn, dizziness, nausea, vomiting, skin reactions, joint pains, and oedema

Pregnancy & Lactation

  • Safety in pregnancy not established
  • Excreted in breast milk
  • Caution advised in lactating mothers

Precautions & Warnings

  • Prolonged use may result in the development of superinfection
  • Administered with care to patients hypersensitive to penicillins
  • May cause a false positive urine glucose result

Use in Special Populations

  • Recommended doses for patients with renal impairment
  • Regular monitoring required for chronic urinary tract infections
  • Paediatric dosages should not exceed those specified for adults

Overdose Effects

  • Non-specific symptoms such as nausea, vomiting, and diarrhoea
  • Supportive treatment recommended

Storage Conditions

  • Suspension should be freshly prepared
  • Reconstituted Suspension should be used within 7-14 days
  • Injection solutions should be used within 2 hours when kept at room temperature
  • Solutions retain potency for 12 hours when stored at 5°C
  • Do not use later than the date of expiry

Related Brands